CD47 and glioblastoma: The data presented here support our hypotheses that combination of CD47 blockade and irradiation or chemotherapy enhances GBM treatment, as irradiation or TMZ in combination with anti-CD47 increased macrophage-dependent phagocytosis of GBM cells and extended survival of GBM-implanted mice.